# QAMZOVA

NDC: 82972-001
Generic name: Meloxicam
Labeler / Manufacturer: Nanjing Delova Biotech Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20251015

FDA application: NDA217593

## Active ingredients

- MELOXICAM: 30 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82972-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82972-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=385fd779-1be1-49ae-8213-750b96ecc997